Skip to main navigation Skip to search Skip to main content

Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era—Is it time for a new paradigm shift? A systematic review and meta-analysis

  • Inge T.A. Peters
  • , Claudia Marchetti
  • , Antonella De Palma
  • , Diana Giannarelli
  • , Antonella Carcagnì
  • , Giovanni Scambia
  • , Anna Fagotti*
  • *Corresponding author

Research output: Contribution to journal › Article

Original languageEnglish
Pages (from-to)77-86
Number of pages10
JournalEuropean Journal of Cancer
Volume187
DOIs
Publication statusPublished - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cytoreductive surgery
  • Epithelial ovarian cancer
  • PARP inhibitors
  • Postoperative residual disease
  • Progression-free survival

Cite this